Home › Bladder Cancer › California › Santa Rosa
Bladder Cancer clinical trials in Santa Rosa, CA
3 studies for Bladder Cancer are looking for participants at sites in and around Santa Rosa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Providence Medical Foundation - Santa Rosa, Santa Rosa
- Providence Santa Rosa Memorial Hospital, Santa Rosa
- Saint Helena Hospital, St. Helena · 14 mi away
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- Providence Medical Foundation, Santa Rosa
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
RecruitingPhase 2/3
- Sutter Santa Rosa, Santa Rosa
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY35 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Boston, MA26 studies
- Baltimore, MD24 studies
- Los Angeles, CA24 studies
- St. Louis, MO22 studies
- Seattle, WA21 studies
- Philadelphia, PA21 studies
- Edison, NJ21 studies
Other studies in Santa Rosa
- Non-Small Cell Lung Cancer17 studies
- Lung Cancer11 studies
- Cancer (all types)11 studies
- Breast Cancer11 studies
- Colorectal Cancer11 studies
- Metastatic Cancer9 studies
- Prostate Cancer9 studies
- Ovarian Cancer7 studies
- Pancreatic Cancer6 studies
- Endometrial Cancer6 studies
- Colon Cancer5 studies
- Stomach Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.